$2.68
-0.1-3.6%
At close: Nov 11, 4:00 PM EST
$2.74
-0.0352-1.27%
Pre-Market: 4:09 AM EST
Anixa Biosciences Inc
ANIXNASDAQ
Anixa Biosciences fell 36.7% from $4.39 to $2.78, behind the S&P 500's +12.7%. Its worst day was Dec 12 (−25.4%), and its low came Jun 10 at $2.35.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Anixa Biosciences closed at its highest level of the year, 18.9% above where the year started.
+9.0% · S&P 500 −0.3%
EPS of $-0.09 beat the $-0.09 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+3.8% · S&P 500 −0.2%
EPS of $-0.08 beat the $-0.09 estimate on $0.00 revenue.
0.0% · S&P 500 −0.2%
EPS of $-0.07 beat the $-0.10 estimate on $0.00 revenue.
+5.5% · S&P 500 +1.7%
D. Boral Capital rated Anixa Biosciences Buy with a $10.00 price target; shares rose 12.1%.
+12.1%, the year's best day · S&P 500 −0.1%
EPS of $-0.08 beat the $-0.08 estimate on $0.00 revenue.
−2.8% · S&P 500 −0.6%
Anixa Biosciences shares rose 11.9%, while the S&P 500 rose 0.6%.
+11.9% · S&P 500 +0.6%
Where it ended: a close of $2.78 on Nov 11, 2026. Up next: Q4 2026 earnings on Jan 11, 2027 (EPS est. $-0.08).
Nothing in the past 12 months.
All ANIX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ANIX and SPY from Benzinga historical bars. Not investment advice.
